0000000000011021

AUTHOR

Hui Cao

showing 9 related works from this author

Disease control and treatment pathways of asthma patients after initiating ICS/LABA

2019

Introduction: GINA guidelines recommend medium dose (MED) and high dose (HD) ICS/LABA as the preferred controller for step 4 asthma patients and clinicians should consider step up/down based on their patients’ asthma control. Limited data is available on how step 4 patients respond to ICS/LABA and how they step up/down in clinical practice. Methods: We conducted a retrospective cohort study using UK Clinical Practice Research Datalink to assess control status of asthma patients in one year after initiating a MED or HD ICS/LABA between 2007 and 2015, and examined their treatment pathways within one year after the treatment initiation. Results: 29,229 and 16, 575 patients initiated MED and HD…

medicine.medical_specialtybiologyExacerbationbusiness.industryOffice visitsRetrospective cohort studyLamamedicine.diseasebiology.organism_classificationDisease controlMedication possession ratioInternal medicineIcs labamedicinebusinesshormones hormone substitutes and hormone antagonistsAsthmaAirway pharmacology and treatment
researchProduct

Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial

2018

IF 6.015 (2017); International audience; Significant evidence from epidemiological investigations showed that dietary polyphenols might manage and prevent type 2 diabetes (T2D). This review summarizes human studies and clinical trials of polyphenols as anti-diabetic agents. Polyphenols from coffee, guava tea, whortleberry, olive oil, propolis, chocolate, red wine, grape seed, and cocoa have been reported to show anti-diabetic effects in T2D patients through increasing glucose metabolism, improving vascular function as well as reducing insulin resistance and HbA1c level. However, individual flavonoid or isoflavonoid compounds appear to have no therapeutic effect on diabetes, based on the lim…

Blood GlucosePolyphenol030309 nutrition & dieteticsFlavonoidType 2 diabetesPharmacologyCarbohydrate metabolismResveratrolIndustrial and Manufacturing Engineering03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyInsulin resistanceIsoflavonoidhuman studyDiabetes mellitusmedicineHumansHypoglycemic AgentspolyphenolsGlycemicchemistry.chemical_classificationtype 2 diabeteClinical Trials as Topicclinical trials0303 health sciencesHypoglycemic Agentbusiness.industryfood and beveragesclinical trialDietary polyphenol04 agricultural and veterinary sciencesGeneral Medicine[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismmedicine.disease040401 food scienceDiet3. Good healthDiabetes Mellitus Type 2chemistrytype 2 diabetesInsulin ResistancebusinessHumanFood ScienceCritical Reviews in Food Science and Nutrition
researchProduct

Dietary polyphenols for managing cancers: What have we ignored?

2020

Abstract Although the chemoprevention and anti-cancer activities of dietary polyphenols have been evidenced through both in vitro and in vivo studies, most of the human clinical trials were unsuccessful or even harmful. Debates on the beneficial roles of dietary polyphenols in cancer therapy are increasing. Many dietary polyphenols studies are conducted by in vitro experiments, but the nature of these studies does not consider the complexity of metabolic processes that are present in vivo. These can often cause instability in the dietary polyphenols, thereby leading to unsuccessful extrapolation into animal or human studies. Dietary polyphenols often have low bioavailability, which is mainl…

0301 basic medicineBioavailabilityCancer therapyMetabolitePharmacology03 medical and health sciences0302 clinical medicineAnti-cancer activityIn vivoMedicineTherapeutic windowCellular metabolismHuman studiesbusiness.industryMicrobiotafood and beveragesDietary polyphenolBioavailability030104 developmental biologyPolyphenol030220 oncology & carcinogenesisCancer cellbusinessStabilityFood ScienceBiotechnology
researchProduct

Abstract LB-130: Combinatorial treatment with intratumoral cytokine mRNAs results in high frequency of tumor rejection and development of anti-tumor …

2018

Abstract Cancer immunotherapy localized to the tumor microenvironment holds great potential to promote innate and adaptive immune responses against tumors, while avoiding toxicities related to systemic administration of immuno-modulatory therapeutics. Current strategies for tumor-targeted, gene-based delivery of immune therapies face limitations in the clinic due to suboptimal target expression, anti-vector immunity, potential for unwanted genomic rearrangements and other off target effects. We developed a highly potent synthetic mRNA-based platform for in vivo transfection and sustained intratumoral expression of immuno-modulatory molecules that is capable of inducing immunity to tumor spe…

0301 basic medicineCancer ResearchTumor microenvironmentbusiness.industrymedicine.medical_treatmentAbscopal effectCancerImmunotherapymedicine.diseaseOncolytic virus03 medical and health sciences030104 developmental biology0302 clinical medicineCytokineImmune systemOncologyCancer immunotherapy030220 oncology & carcinogenesisCancer researchmedicinebusinessCancer Research
researchProduct

Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models

2021

Local immunotherapy ideally stimulates immune responses against tumors while avoiding toxicities associated with systemic administration. Current strategies for tumor-targeted, gene-based delivery, however, are limited by adverse effects such as off-targeting or antivector immunity. We investigated the intratumoral administration of saline-formulated messenger (m)RNA encoding four cytokines that were identified as mediators of tumor regression across different tumor models: interleukin-12 (IL-12) single chain, interferon-α (IFN-α), granulocyte-macrophage colony-stimulating factor, and IL-15 sushi. Effective antitumor activity of these cytokines relied on multiple immune cell populations and…

Messenger RNAAntitumor immunitybusiness.industrymedicine.medical_treatmentRNANeoplasms therapyGeneral MedicineImmunotherapyArticleImmune systemNeoplasmsCancer researchSystemic administrationCytokinesHumansMedicineRNA MessengerbusinessGeneScience Translational Medicine
researchProduct

Valorization of kiwi agricultural waste and industry by-products by recovering bioactive compounds and applications as food additives : a circular ec…

2021

Currently, agricultural production generates large amounts of organic waste, both from the maintenance of farms and crops (agricultural wastes) and from the industrialization of the product (food industry waste). In the case of Actinidia cultivation, agricultural waste groups together leaves, flowers, stems and roots while food industry by-products are represented by discarded fruits, skin and seeds. All these matrices are now underexploited and so, they can be revalued as a natural source of ingredients to be applied in food, cosmetic or pharmaceutical industries. Kiwifruit composition (phenolic compounds, volatile compounds, vitamins, minerals, dietary fiber, etc.) is an outstanding basis…

food.ingredientFood industryCircular economy030309 nutrition & dietetics3308 Ingeniería y Tecnología del Medio AmbienteAntioxidants12. Responsible consumptionAnalytical Chemistry3101.08 Productos Agrícolas no AlimenticiosAgricultura sostenible03 medical and health sciences0404 agricultural biotechnologyNutraceuticalfood3103.08 Gestión de la Producción VegetalFood IndustryAgricultural productivity2. Zero hunger0303 health sciencesbusiness.industryCircular economyFood additiveKiwi residuesContaminació agrícolafood and beveragesAgriculture04 agricultural and veterinary sciencesGeneral MedicineBiodegradable wasteVitaminsPulp and paper industry040401 food scienceEnvironmentally friendlyPhenolic compoundsAgricultureFruitSeedsFood applicationsFood AdditivesbusinessFood Science
researchProduct

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK p…

2020

Abstract Introduction Global Initiative for Asthma (GINA) recommends medium- or high-dose inhaled corticosteroid-long-acting β2-agonist (ICS-LABA) as preferred treatments for patients with moderate-to-severe asthma. Limited data is available on how step 4/5 patients respond to ICS-LABA and how they step up/down in clinical practice. Methods This retrospective cohort study assessed the characteristics, control status, treatment pathways, and healthcare resource utilization in patients with asthma during one year after initiating medium- or high-dose ICS-LABA. Data from the United Kingdom Clinical Practice Research Datalink were analysed between January 01, 2006 and February 28, 2016. Results…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classLeukotriene receptorbusiness.industryAntagonistMuscarinic antagonistRetrospective cohort studyLamamedicine.diseasebiology.organism_classification03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineCohortmedicineCorticosteroid030212 general & internal medicinebusinessAsthmamedicine.drugRespiratory Medicine
researchProduct

Camellia japonica : A phytochemical perspective and current applications facing its industrial exploitation

2022

In response to the increased popularity of medicinal plants, a number of conservation groups are recommending the investigation on poorly characterized and widely distributed species, as it is the case of camellias. In particular, Camellia japonica L. is a widespread species found in Galicia (NW Spain), where it has been largely exploited with ornamental purposes. Recent findings on its phytochemical characterization showed thousands of bioactive ingredients, mostly represented by phenolic compounds, together with terpenoids, and fatty acids. These molecules present associated biological activities, acting as antioxidant, antimicrobial, anti-inflammatory, and anticancer agents. This review …

Food scienceMedicinal plantsBiological activitiesBiochemical valorizationPlantes medicinalsAnalytical ChemistryCamelliasNatural bioactive compoundsPlantes Nutrició
researchProduct

Extraction of lipids from microalgae using classical and innovative approaches

2022

Microalgae, as a photosynthetic autotrophic organism, contain a variety of bioactive compounds, including lipids, proteins, polysaccharides, which have been applied in food, medicine, and fuel industries, among others. Microalgae are considered a good source of marine lipids due to their high content in unsaturated fatty acid (UFA) and can be used as a supplement/replacement for fish-based oil. The high concentration of docosahexaenoic (DHA) and eicosapentaenoic acids (EPA) in microalgae lipids, results in important physiological functions, such as antibacterial, anti-inflammatory, and immune regulation, being also a prerequisite for its development and application. In this paper, a variety…

Biological activityExtractionGeneral MedicineLipidsAntioxidantsAnalytical Chemistry3101.08 Productos Agrícolas no Alimenticios2302.90 Bioquímica de AlimentosEicosapentaenoic AcidAlguesDietary SupplementsMicroalgaeAnimalslipids (amino acids peptides and proteins)AntiinflamatorisFood Science
researchProduct